PHARMACY CARE DOXYLAMINE SLEEP doxylamine succinate 25 mg tablet blister pack (New Formulation)

Land: Australien

Sprache: Englisch

Quelle: Department of Health (Therapeutic Goods Administration)

Wirkstoff:

doxylamine succinate, Quantity: 25 mg

Verfügbar ab:

Cipla Australia Pty Ltd

INN (Internationale Bezeichnung):

doxylamine succinate

Darreichungsform:

Tablet, uncoated

Zusammensetzung:

Excipient Ingredients: microcrystalline cellulose; maize starch; lactose monohydrate; magnesium stearate; purified water

Verabreichungsweg:

Oral

Einheiten im Paket:

20

Verschreibungstyp:

(S3) Pharmacist Only Medicine

Anwendungsgebiete:

For temporary relief of sleeplessness

Produktbesonderheiten:

Visual Identification: white to off white, circular, biconvex uncoated tablets, central breakline on one side and plain on; Container Type: Blister Pack; Container Material: PVC/PE/PVDC/Al; Container Life Time: 24 Months; Container Temperature: Store below 30 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Berechtigungsstatus:

Licence status A

Berechtigungsdatum:

2015-03-03